United States · FDA National Drug Code directory
Terbinafine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-250_9c427fa5-f0ef-593a-376a-0de7943c4057
- Product NDC
- 55111-250
- Form
- TABLET
- Composition / generic term
- Terbinafine Hydrochloride
- Labeler
- Dr.Reddys Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070702
- Source listing expiry
- 20261231
Source-listed ingredients
- TERBINAFINE HYDROCHLORIDE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (55111-250-01) · 55111-250-01
- 500 TABLET in 1 BOTTLE (55111-250-05) · 55111-250-05
- 30 TABLET in 1 BOTTLE (55111-250-30) · 55111-250-30
- 10 BLISTER PACK in 1 CARTON (55111-250-79) / 10 TABLET in 1 BLISTER PACK (55111-250-78) · 55111-250-79
- 90 TABLET in 1 BOTTLE (55111-250-90) · 55111-250-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →